GlycoMimetics to Report Third-Quarter 2017 Financial Results on November 8, 2017
The dial-in number for the conference call is (844) 413-7154 for
domestic participants and (216) 562-0466 for international participants
with participant code 8794188. A webcast replay will be available via
the “Investors” tab on the
About
GlycoMimetics is a clinical-stage biotechnology company focused on the
discovery and development of novel glycomimetic drugs to address unmet
medical needs resulting from diseases in which carbohydrate biology
plays a key role.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171101005804/en/
Source:
GlycoMimetics, Inc.
Investor Contact:
Shari Annes, 650-888-0902
sannes@annesassociates.com
or
Media
Contact:
Jamie Lacey-Moreira, 410-299-3310
jamielacey@presscommpr.com